Quarterly claims data reveals the explosive growth of GLP-1 drugs — who's
prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to
make agonizing choices, sacrificing fundamental necessities to cope with the
escalating burden of healthcare costs.
Quarterly claims data reveals the explosive growth of ADC Oncology drugs — who's
prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to
make agonizing choices, sacrificing fundamental necessities to cope with the
escalating burden of healthcare costs.
Access the full interactive walkthrough in desktop view.
"For too long, healthcare data has been scattered and siloed. We’re here to clear the
data fog and give finance experts a clear path to unlocking its potential. This is the
vision guiding my team."
Jim Plante CEO
Frequently Asked Questions
Everything you need to know about IMX Data
Healthcare claims data built for institutional investors, hedge funds, and quant funds.
Can't find what you're looking for? Contact us.
SOC 2 Type II Certified
All data de-identified per HIPAA Safe Harbor (45 CFR 164.514(b)). SOC 2 Type II
certified in 2025.Enterprise-grade security and compliance for institutional clients.